Alexandar Tzankov
Alexandar Tzankov is an expert in Hematology at University Children’s Hospital Basel (Switzerland). As of October 2026, ScienceLeadR ranks Alexandar Tzankov in the top 1% of experts worldwide for Lymphoma, Lymphoproliferative Disorders and Coronavirus Infections. Alexandar Tzankov has authored 610 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 1 of them ongoing. SLR score: 1,967 (community average: 125). How the SLR is computed.
LeadR Profile
Hematology
Subspecialties: Oncology - Immunology - Genetics
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2000 - 2026
Number : 610
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Insights into the pathophysiology of post-COVID lung disease from the perspective of histopathology. PMID 42858306 — cells, lung, pathology, immunity, lung diseases | Pathobiology | 2026 | 0 |
| ICSH Guidance on Bone Marrow Examination and Reporting. PMID 42695770 — bone marrow, hematology, classification, bone marrow examination | Int J Lab Hematol | 2026 | 0 |
| TCR γδ cell-specific STAT5 gain of function induces a druggable chronic human immune dysregulation. PMID 42577896 — cells | J Hum Immun | 2026 | 0 |
| Clinical Images: Features of IgG4-related disease in a patient with granulomatosis with polyangiitis. PMID 42563429 — immunoglobulin g4-related disease, granulomatosis with polyangiitis | ACR Open Rheumatol | 2026 | 0 |
| The histopathological differential diagnosis of BPDCN and other plasmacytoid dendritic cell proliferations. PMID 42563016 — cells, diagnosis, differential, hematologic neoplasms, neoplasms, pathology, phenotype, diagnosis, dendritic cells | Virchows Arch | 2026 | 0 |
Clinical Studies 7
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma NCT05700149 — cells, lymphoma, b-cell, lymphoma, lymphoma, b-cell, marginal zone, b-lymphocytes | N/A | Recruiting | 2024 |
LeadR Networks
Main global connection map